National Comprehensive Cancer Network



About NCCN

Head and Neck Cancers Panel - Disclosures as of 2/28/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

David M. Brizel, MD

None

medical legal case unrelated to any nccn activities

None

None

6/16/2014

Paul M. Busse, MD, PhD

None

None

None

None

8/18/2014

Jimmy J. Caudell, MD, PhD

None

Boehringer Ingelheim GmbH

None

None

6/5/2014

Anthony J. Cmelak, MD

None

Amgen Inc.

None

None

6/5/2014

A. Dimitrios Colevas, MD

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Exelixis Inc.;
Genentech, Inc.;
GlaxoSmithKline;
actogenix;
ecog;
NCI;
rtog

None

None

None

6/4/2014

Frank Dunphy, MD

Bristol-Myers Squibb Company

None

None

None

5/22/2014

David W. Eisele, MD, FACS

None

None

None

None

6/4/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

12/8/2014

Jill Gilbert, MD

National Cancer Institute;
Eastern Cooperative Oncology Group

None

None

None

6/9/2014

Maura L. Gillison, MD, PhD

None

None

None

None

8/1/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Robert I. Haddad, MD

None

None

None

None

7/29/2014

Bruce H. Haughey, MBChB, MS

None

None

None

None

5/29/2014

Wesley L. Hicks, MD

None

None

None

None

7/11/2014

Ying J. Hitchcock, MD

None

None

None

None

6/10/2014

Miranda Hughes, PhD

None

None

None

None

11/7/2014

Antonio Jimeno, MD, PhD

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Oncothyreon;
VentiRX Pharmaceuticals

None

None

None

6/9/2014

Merrill S. Kies, MD

None

None

None

None

1/11/2014

William M. Lydiatt, MD

None

None

None

None

6/4/2014

Ellie Maghami, MD

None

None

None

None

6/4/2014

Renato Martins, MD, MPH

Bayer HealthCare;
Eisai Inc.;
Exelixis Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

3/28/2014

Thomas McCaffrey, MD, PhD

None

None

None

None

6/5/2012

Joan S. McClure, MS

None

None

None

None

12/8/2014

Nicole McMillian, MS

None

None

None

None

10/8/2014

Loren K. Mell, MD

None

None

None

None

5/1/2014

Bharat B. Mittal, MD

None

None

None

None

5/12/2014

David G. Pfister, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Exelixis Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

5/29/2014

Harlan A. Pinto, MD

Bristol-Myers Squibb Company

Eli Lilly and Company

None

None

8/9/2014

John A. Ridge, MD, PhD, FACS

None

None

None

None

6/2/2014

Sandeep Samant, MD

None

None

None

None

7/1/2014

David E. Schuller, MD

None

None

None

National Cancer Institute

3/20/2013

Jatin P. Shah, MD, PhD

None

None

None

None

10/16/2014

Sharon Spencer, MD

None

None

None

None

6/13/2014

Sarika Trikha, PharmD

None

None

None

None

11/11/2014

Randal S. Weber, MD

None

None

None

None

6/5/2014

Gregory Wolf, MD

None

None

None

None

5/2/2014

Frank Worden, MD

Pfizer Inc.

Baxter International Inc.;
Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Onyx Pharmaceuticals, Inc.

None

None

1/10/2014

Sue S. Yom, MD, PhD

Genentech, Inc.

None

None

None

5/4/2014